Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Mouth Neoplasms 2Breast Neoplasms 2Tobacco Use Disorder 1Stomatitis 1Precancerous Conditions 1Neoplasms 1Multiple Myeloma 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Immunoglobulin Light-chain Amyloidosis 1Head and Neck Neoplasms 1Fanconi Anemia 1Erythroplasia 1

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Spectrometry, Fluorescence × Clear all
NCT00507182 2018-01-19

Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions

M.D. Anderson Cancer Center

Phase NA Completed
381 enrolled
Head & Neck

Mouth Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡